Mechanistically, Holzgruber et al. showed that type I interferon signaling in melanoma cells can induce PD-1 expression via the IFNAR–JAK/STAT axis, which has implications for how tumor-intrinsic IFN pathways modulate checkpoint receptor expression and response to therapy [108]. This evidence concerns the gene IFNA1 and neoplasm.